Clinical Report: Resveratrol and Diabetic Retinopathy

Overview

This systematic review highlights the potential of resveratrol as a multi-target modulator in early diabetic retinopathy (DR). Resveratrol demonstrates protective effects on mitochondrial health, inflammation, and the blood-retinal barrier, suggesting it may modify early DR progression.

Background

Diabetic retinopathy (DR) is a leading cause of vision loss among diabetic patients, with current treatments primarily addressing advanced stages of the disease. There is a critical need for preventive strategies that target early neuroinflammatory and metabolic disturbances. Resveratrol, a naturally occurring polyphenol, has emerged as a potential candidate for modulating these early pathological processes.

Data Highlights

Key Findings

Clinical Implications

{'issues': 'Expand on bioavailability and delivery methods as critical challenges.'}

Conclusion

The findings from this review underscore the importance of exploring upstream interventions in diabetic retinopathy management, particularly those targeting neuroinflammation and mitochondrial dysfunction.

Related Resources & Content

1. Asanad, S., Retinal Physician, 2025 -- Dietary Nutrients and Diabetic Retinopathy
2. Bhavsar, A. R., Retinal Physician, 2004 -- Landmark Laser Trials Continue to Govern Standard of Care in Diabetic Retinopathy
3. ADA, PubMed, 2026 -- Standards of Care in Diabetes-2026
4. Retinal Physician — Dietary Nutrients and Diabetic Retinopathy
5. Retinal Physician — Clinical Trials Provide Rationale for Use of Anti-VEGF Treatment Earlier in Diabetic Retinopathy
6. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 - PubMed
7. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials - PubMed